Your browser doesn't support javascript.
loading
Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer.
Burton, Kimberly A; Mahen, Elisabeth; Konnick, Eric Quentin; Blau, Sibel; Dorschner, Michael O; Ramirez, Arturo B; Schmechel, Stephen C; Song, Chaozhong; Parulkar, Rahul; Parker, Stephanie; Senecal, Francis Mark; Pritchard, Colin C; Mecham, Brigham H; Szeto, Christopher; Spilman, Patricia; Zhu, Jingchun; Gadi, Vijayakrishna K; Ronen, Roy; Stilwell, Jackie; Kaldjian, Eric; Dutkowski, Janusz; Benz, Stephen Charles; Rabizadeh, Shahrooz; Soon-Shiong, Patrick; Blau, C Anthony.
Afiliación
  • Burton KA; Department of Medicine, University of Washington, Seattle, WA.
  • Mahen E; Center for Cancer Innovation, University of Washington, Seattle, WA.
  • Konnick EQ; Northwest Medical Specialties, Puyallup and Tacoma, WA.
  • Blau S; South Sound CARE Foundation, Seattle, WA.
  • Dorschner MO; Center for Cancer Innovation, University of Washington, Seattle, WA.
  • Ramirez AB; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA.
  • Schmechel SC; Department of Medicine/Hematology, University of Washington, Seattle, WA.
  • Song C; Department of Laboratory Medicine, University of Washington, Seattle, WA.
  • Parulkar R; Center for Cancer Innovation, University of Washington, Seattle, WA.
  • Parker S; Northwest Medical Specialties, Puyallup and Tacoma, WA.
  • Senecal FM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
  • Pritchard CC; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA.
  • Mecham BH; Center for Precision Diagnostics, University of Washington, Seattle, WA.
  • Szeto C; Rarecyte Inc, Seattle, WA.
  • Spilman P; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
  • Zhu J; Center for Cancer Innovation, University of Washington, Seattle, WA.
  • Gadi VK; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA.
  • Ronen R; Department of Medicine/Hematology, University of Washington, Seattle, WA.
  • Stilwell J; NantHealth, Culver City, CA.
  • Kaldjian E; Northwest Medical Specialties, Puyallup and Tacoma, WA.
  • Dutkowski J; South Sound CARE Foundation, Seattle, WA.
  • Benz SC; Northwest Medical Specialties, Puyallup and Tacoma, WA.
  • Rabizadeh S; South Sound CARE Foundation, Seattle, WA.
  • Soon-Shiong P; Department of Laboratory Medicine, University of Washington, Seattle, WA.
  • Blau CA; Trialomics, Seattle, WA.
JCO Precis Oncol ; 6: e2100280, 2022 03.
Article en En | MEDLINE | ID: mdl-35294224
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos